Sökning: "uterine contractility"
Visar resultat 1 - 5 av 8 avhandlingar innehållade orden uterine contractility.
1. Misoprostol : pharmacokinetics and effects on uterine contractility and cervical ripening in early pregnancy
Sammanfattning : Misoprostol is an orally active synthetic PGE1 analogue which has become an important drug in obstetric and gynaecological practice because of its uterotonic and cervical priming actions. It is safe, cheap, widely available and stable at room temperature. LÄS MER
2. Receptor-mediated uterine effects of oxytocin and vasopressin
Sammanfattning : The neurohypophyseal hormones oxytocin and vasopressin are important in the regulation of uterine contractility. These hormones, as well as prostaglandin F2α, are most forceful myometrial tissue contractors. LÄS MER
3. The uterine proteoglycan expression in pregnancy and labor
Sammanfattning : Objective: Protracted labor is a common clinical problem causing maternal and fetal complications. It is the leading indication for caesarean sections throughout the world, and emphasizes our need to be able to control labor. LÄS MER
4. OXYTOCIN AND VASOPRESSIN IN UTERINE ACTIVITY. Receptor-mediated agonism and antagonism with special regard to the aetiology and treatment of preterm labour and primary dysmenorrhoea
Sammanfattning : With a view to the aetiology and treatment of preterm labour and primary dysmenorrhoea we studied the influence of sexual steroids on the plasma levels of oxytocin and vasopressin, effect of these peptides on uterine contractility in vitro and in vivo, receptor concentrations and antagonists to oxytocin and vasopressin. In postmenopausal women oestrogen increased the concentrations in plasma of both peptides, whereas progesterone increased oxytocin but decreased vasopressin levels. LÄS MER
5. Improving medical abortion : using mifepristone in combination with a prostaglandin analogue
Sammanfattning : Background: Induced abortion is still a major health problem in the world and the most frequently performed intervention in Obstetrics and Gynaecology with an estimated total of 46 millions worldwide each year. Medical abortion with mifepristone and prostaglandin was first introduced in 1988, and is now approved in 29 countries. LÄS MER